Aemetis, Inc. (NASDAQ:AMTX) Receives $12.95 Consensus PT from Brokerages

Shares of Aemetis, Inc. (NASDAQ:AMTX) have been assigned an average rating of “Moderate Buy” from the five analysts that are currently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating on the company. The average 12-month target price among brokers that have issued a report on the stock in the last year is $12.95.

A number of research analysts recently issued reports on the company. Ascendiant Capital Markets reduced their price objective on Aemetis from $20.00 to $19.00 and set a “buy” rating for the company in a research report on Tuesday, September 3rd. Truist Financial reissued a “hold” rating and set a $3.50 price target (down previously from $4.00) on shares of Aemetis in a report on Wednesday, July 31st. StockNews.com raised shares of Aemetis to a “sell” rating in a report on Wednesday, July 31st. UBS Group cut their price objective on shares of Aemetis from $8.25 to $7.75 and set a “buy” rating on the stock in a research report on Monday, August 19th. Finally, HC Wainwright restated a “buy” rating and issued a $28.00 target price on shares of Aemetis in a research report on Friday, November 15th.

Institutional Trading of Aemetis

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Geode Capital Management LLC lifted its position in Aemetis by 7.7% in the third quarter. Geode Capital Management LLC now owns 924,293 shares of the specialty chemicals company’s stock worth $2,126,000 after purchasing an additional 66,031 shares during the period. State Street Corp raised its stake in shares of Aemetis by 36.1% in the 3rd quarter. State Street Corp now owns 699,089 shares of the specialty chemicals company’s stock worth $1,608,000 after buying an additional 185,304 shares in the last quarter. Susquehanna Fundamental Investments LLC lifted its holdings in shares of Aemetis by 287.4% in the second quarter. Susquehanna Fundamental Investments LLC now owns 126,078 shares of the specialty chemicals company’s stock valued at $379,000 after buying an additional 93,536 shares during the period. Bank of New York Mellon Corp bought a new position in Aemetis during the second quarter valued at about $306,000. Finally, Wellington Management Group LLP acquired a new position in Aemetis during the third quarter worth about $177,000. 27.02% of the stock is currently owned by institutional investors.

Aemetis Stock Performance

Aemetis stock opened at $3.93 on Friday. Aemetis has a 1 year low of $2.10 and a 1 year high of $7.03. The firm’s 50-day moving average is $2.87 and its 200-day moving average is $3.05. The company has a market cap of $195.48 million, a P/E ratio of -1.74 and a beta of 1.23.

Aemetis (NASDAQ:AMTX) last issued its earnings results on Tuesday, November 12th. The specialty chemicals company reported ($0.38) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.47) by $0.09. The business had revenue of $81.44 million during the quarter, compared to the consensus estimate of $77.79 million. During the same period in the prior year, the business earned ($0.59) EPS. As a group, sell-side analysts predict that Aemetis will post -2.1 earnings per share for the current year.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.